![Sofien Dessolin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Sofien Dessolin is the founder of Cell&Co SAS.
He held the titles of Chairman, CFO & Chief Scientific Officer at the company.
Sofien Dessolin active positions
Companies | Position | Start |
---|---|---|
Cell&Co SAS
![]() Cell&Co SAS Miscellaneous Commercial ServicesCommercial Services Part of CryoPort, Inc., Cell&Co SAS is a premium solution provider for logistic and storage of biological samples and pharmaceutical products. The company is based in Clermont-Ferrand, France. The French company offers compliant and high-quality services for clinical studies of phase I, II, and III, with tailored solutions for precision biomedical research. In addition to storing biocollections in ultra-secure BPF infrastructures, Cell&Co provides centralized management of all logistics flows. The company was founded by Sofien Dessolin, Florent Belon, Alexandre Léglise, Michel Pautrat, Jean-François Félix. Florent Belon has been the CEO since incorporation. Cell&Co was acquired by CryoPort, Inc. on April 18, 2022 for $9.38 million. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Cell&Co SAS
![]() Cell&Co SAS Miscellaneous Commercial ServicesCommercial Services Part of CryoPort, Inc., Cell&Co SAS is a premium solution provider for logistic and storage of biological samples and pharmaceutical products. The company is based in Clermont-Ferrand, France. The French company offers compliant and high-quality services for clinical studies of phase I, II, and III, with tailored solutions for precision biomedical research. In addition to storing biocollections in ultra-secure BPF infrastructures, Cell&Co provides centralized management of all logistics flows. The company was founded by Sofien Dessolin, Florent Belon, Alexandre Léglise, Michel Pautrat, Jean-François Félix. Florent Belon has been the CEO since incorporation. Cell&Co was acquired by CryoPort, Inc. on April 18, 2022 for $9.38 million. | Commercial Services |
- Stock Market
- Insiders
- Sofien Dessolin